SC
BSX icon

Syon Capital’s Boston Scientific BSX Stock Holding History

Syon Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$951K Sell
22,272
-1,883
-8% -$102K 0.04% 373
2026
Q1 		$1.52M Sell
24,155
-3,746
-13% -$300K 0.08% 195
2025
Q4 		$2.66M Buy
27,901
+691
+3% +$67.7K 0.13% 116
2025
Q3 		$2.66M Buy
27,210
+1,745
+7% +$181K 0.14% 101
2025
Q2 		$2.74M Buy
25,465
+4,277
+20% +$433K 0.18% 81
2025
Q1 		$2.14M Buy
21,188
+2,239
+12% +$225K 0.17% 88
2024
Q4 		$1.69M Sell
18,949
-1,009
-5% -$88.8K 0.15% 98
2024
Q3 		$1.67M Buy
19,958
+20
+0.1% +$1.58K 0.15% 104
2024
Q2 		$1.54M Buy
19,938
+307
+2% +$22.5K 0.14% 109
2024
Q1 		$1.34M Buy
19,631
+562
+3% +$36.1K 0.13% 120
2023
Q4 		$1.1M Buy
19,069
+819
+4% +$43.7K 0.11% 129
2023
Q3 		$964K Buy
+18,250
New +$957K 0.12% 110

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Syon Capital's BSX Position: Q2 2026 in Review

Syon Capital reduced its Boston Scientific (BSX) stake by 7.8% in Q2 2026, selling an estimated $102K and leaving 22,272 shares worth $951K. The position accounts for 0.04% of the portfolio, ranked #373.

Syon Capital first reported a position in BSX in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.74M in Q2 2025. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Syon Capital held 22,272 shares of Boston Scientific worth $951K as of Q2 2026.
  • Syon Capital sold 1,883 Boston Scientific shares in Q2 2026, an estimated $102K.
  • Boston Scientific made up 0.04% of Syon Capital's portfolio in Q2 2026, its #373 holding.
  • Syon Capital first reported a position in Boston Scientific in Q3 2023 and has held it in 12 quarters since.
  • Syon Capital's Boston Scientific position peaked at $2.74M in Q2 2025.
  • 1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.